Cell adhesion
and cell migration play important roles in variety of physiological
and pathological processes such as embryonic development, cancer metastasis,
blood vessel formation and remodeling, and inflammation. Our laboratory
aims to understand the molecules involved in cell adhesion and cell
migration and the ways in which they control adhesion and migration
of cells in both physiological and pathological processes. Integrin
is a major family of adhesion proteins and essential for both cell adhesiveness
and cell motility. To understand the molecular mechanism of integrin-mediated
cell adhesion and cell migration, the research in our lab is being focused
on the roles of integrin-associated proteins in the integrin-dependent
biological events such as cancer invasion, metastasis, and angiogenesis.
We recently identified a novel protein ICAP-1 that associates with the
cytoplasmic domain of b1 integrin and found that ICAP-1 regulates cell
movement. ICAP-1 is a ubiquitously expressed intracellular phosphoprotein
and contains a PH domain and multiple sites that are phosphorylated
by several important signaling enzymes such as PKC, PKA and CamKII.
Future study will be directed to the functional analysis of these structural
motifs of ICAP-1 in cell adhesion, migration, and integrin signaling.
In parallel, we also study the tetraspanin protein that associated with
the extracellular domain of b1 integrin. One of the tetraspanins, KAI1/CD82,
has been identified as a cancer metastasis suppressor. Metastatic or
invasive cancer is usually accompanied with the loss of KAI1/CD82 expression.
The mechanism of KAI1/CD82-mediated inhibition of cancer invasion and
metastasis remains unclear. We have identified that the FAK-Src-p130
CAS/CrkII-Rac pathway was important for the KAI1/CD82-mediated suppression
of cell motility and invasiveness in prostate cancer. During the KAI1/CD82
study, we discovered a novel transmembrane protein that physically associated
with tetraspanins and belonged to the immunoglobulin superfamily (IgSF).
This IgSF protein, called EWI2/PGRL/KASP, directly regulates cell motility
and is likely to be important for KAI1/CD82’s inhibitory activity.
These findings will provide mechanistic insight into the cancer metastasis
suppression mediated by KAI1/CD82.
Recent Publications
Zhang XA,
He B, Zhou B and Liu L. Requirement of p130CAS-Crk coupling in KAI1/CD82-mediated
suppression of cell migration. J Biol Chem 278:27319-27328,
2003.
Zhang XA, Lane WS, Charrin S, Rubinstein E and Liu L. EWI2/PGRL Associates
with the Metastasis Suppressor KAI1/CD82 and Inhibits the Migration
of Prostate Cancer Cells. Cancer Research 63:2665-2674, 2003.
Zhang XA., Kazarov AR, Yang X, Bontrager AL, Stipp CS and Hemler ME.
Function of the tetraspanin CD151-a6b1 integrin complex during cellular
morphogenesis. Mol Biol Cell 13:1-11, 2002.
Zhang XA, Bontrager AL and Hemler ME. Transmembrane 4 superfamily proteins
associate with activated protein kinase C (PKC) and link PKC to specific
b1 integrins. J Biol Chem 276:25005-25013, 2001.
Zhang, XA, Bontrager AL, Bazzoni G, Kraeft SK, Stipp CS, Chen LB and
Hemler ME. Phosphorylation of a conserved integrin a3 chain QPSXXE motif
regulates signaling, motility, and cytoskeletal engagement. Mol
Biol Cell 12:351-365, 2001.
Zhang XA and Hemler ME. Interaction of the integrin b1 cytoplasmic domain
with ICAP protein. J Biol Chem 274:11-19, 1999.
[HOME] [CENTER]
[DIRECTOR] [FACULTY]
[WORKING GROUP] [INJURY
LAB] [TAM]
[TAM INVESTIGATORS]
[TAM TRIALS] [NEWS]
[GIVING]